Satoru Shinriki
Kumamoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
A 57-year-old male case of high temperature requirement A serine peptidase 1 (HTRA1)-related cerebral small vessel disease with "Chocolate Chip Sign" on susceptibility-weighted imaging
Journal: Rinsho shinkeigaku = Clinical neurology
Published: December 10, 2025
Clinical utility of a comprehensive genomic profiling test for patient with advanced biliary tract cancer.
Journal: International journal of clinical oncology
Published: July 07, 2024
Prognostic Significance of Serum Interleukin-6 Levels in Oral Squamous Cell Carcinoma.
Journal: Cureus
Published: February 19, 2024
Biallelic disruption of DDX41 activity is associated with distinct genomic and immunophenotypic hallmarks in acute leukemia.
Journal: Frontiers in oncology
Published: January 28, 2023
Ribosome profiling analysis reveals the roles of DDX41 in translational regulation.
Journal: International journal of hematology
Published: November 04, 2022
Potential use of EGFR-targeted molecular therapies for tumor suppressor CYLD-negative and poor prognosis oral squamous cell carcinoma with chemoresistance.
Journal: Cancer cell international
Published: August 10, 2022
Unique role of DDX41, a DEAD-box type RNA helicase, in hematopoiesis and leukemogenesis.
Journal: Frontiers in oncology
Published: July 12, 2022
Detection of Vascular Notch3 Deposits in Unfixed Frozen Skin Biopsy Sample in CADASIL.
Journal: Frontiers in neurology
Published: February 22, 2022
The Tumour Suppressor CYLD Is Required for Clathrin-Mediated Endocytosis of EGFR and Cetuximab-Induced Apoptosis in Head and Neck Squamous Cell Carcinoma.
Journal: Cancers
Published: November 29, 2021
DDX41 is required for cGAS-STING activation against DNA virus infection.
Journal: Cell reports
Published: May 20, 2021
Last Updated: 09/26/2026